Introduction. Alexithymia is manifested by limited abilities to identify and express emotions and is a possible risk factor for the onset and treatment of the disease. Objective. To determine the dependence of the presence of alexithymia in patients with chronic lung and heart diseases. Methodology and results. One hundred respondents aged 35 to 75 participated in the research, 50% of whom were being treated for chronic lung diseases, and 50% for chronic heart diseases. After filling out the Toronto Twenty-Point Scale (TAS-20) questionnaire, the degree of alexithymia was determined. Using the Chi-square test for independence, it was determined that the presence of alexithymia and chronic heart and lung diseases were dependent characteristics (p > 0.0005), and a significantly larger number of respondents with established alexithymia were treated for chronic lung diseases. Using the Chi-square test, it was shown that the presence of alexithymia and the gender of the subject were not dependent characteristics, while the non-parametric Mann-Whitney U test of significance was used to analyze the dependence of alexithymia and the age of the subject. It demonstrated that there was a statistically significant difference in the age of the subjects with and without alexithymia (p < 0.05). Conclusion. In this paper, we found that alexithymia is a more significant risk factor for the occurrence of chronic impairment of lung function in relation to heart disease.
References
1.
Serrano J, Plaza V, Sureda B, de Pablo J, Picado C, Bardagí S, et al. Alexithymia: a relevant psychological variable in near-fatal asthma. European Respiratory Journal. 2006;28(2):296–302.
2.
Kušević Z, Marušić K. Povezanost aleksitimije i morbiditeta. Liječnički vjesnik. 2014;136(1–2):0–0.
3.
Lehrer P, Kaur K, Sharma A, Shah K, Huseby R, Bhavsar J, et al. Heart Rate Variability Biofeedback Improves Emotional and Physical Health and Performance: A Systematic Review and Meta Analysis. Applied Psychophysiology and Biofeedback. 2020;45(3):109–29.
4.
Zhu J, Ji L, Liu C. Heart rate variability monitoring for emotion and disorders of emotion. Physiological Measurement. 40(6):064004.
5.
Tselebis A, Kosmas E, Bratis D, Moussas G, Karkanias A, Ilias I, et al. Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. Annals of General Psychiatry. 2010;9(1).
6.
Han D, Zhang Y, Li B, Lv Z, Huo X, Li Y, et al. Alexithymia in Chinese chronic obstructive pulmonary disease (COPD) patients: The prevalence and related factors of alexithymia. Psychiatry Research. 2012;198(2):274–8.
7.
S SR. Prediktivni značaj prisustva aleksitimije u proceni anksioznosti i depresivnosti kod studenata obolelih od bronhijalne astme. 2018.
8.
Grabe HJ, Frommer J, Ankerhold A, Ulrich C, Gröger R, Franke GH, et al. Alexithymia and Outcome in Psychotherapy. Psychotherapy and Psychosomatics. 2008;77(3):189–94.
9.
Vanheule S, Verhaeghe P, Desmet M. In search of a framework for the treatment of alexithymia. Psychology and Psychotherapy: Theory, Research and Practice. 2011;84(1):84–97.
10.
Feldman JM, Lehrer PM, Hochron SM. The predictive value of the Toronto Alexithymia Scale among patients with asthma. Journal of Psychosomatic Research. 2002;53(6):1049–52.
11.
Brown EL, Fukuhara JT, Feiguine RJ. Alexithymic Asthmatics: The Miscommunication of Affective and Somatic States. Psychotherapy and Psychosomatics. 1981;36(2):116–21.
12.
Bagby M, Taylor G. Affect dysregulation and alexithymia. Disorders of Affect Regulation. 1997. p. 26–45.
13.
Kanbara K, Fukunaga M. Links among emotional awareness, somatic awareness and autonomic homeostatic processing. BioPsychoSocial Medicine. 2016;10(1).
14.
Rokvić N, Jovanović T. Alexithymia measured with the TAS-20 questionnaire: Determining the validity of the factor structure and its relation to life satisfaction and the Big Five personality traits. Psiholoska istrazivanja. 2018;21(1):23–40.
15.
Trajanovic N, Djuric V, Latas M, Milovanovic S, Jovanovic A, Djuric D. Serbian translation of the 20-item toronto alexithymia scale: Psychometric properties and the new methodological approach in translating scales. Srpski arhiv za celokupno lekarstvo. 2013;141(5–6):366–70.
16.
Lazarević M, Jovović S. Psihosomatske reakcije i hipertenzija u uslovima stresa. Opšta medicina. 2017;23:1–2.
17.
Matti J, Luutonen S, Reventlow HV, Patterson P, Karlsson H, Salokangas RKR. Alexithymia and Childhood Abuse Among Patients Attending Primary and Psychiatric Care: Results of the RADEP Study. Psychosomatics. 2008;49(4):317–25.
18.
Joukamaa M, Taanila A, Miettunen J, Karvonen JT, Koskinen M, Veijola J. Epidemiology of alexithymia among adolescents. Journal of Psychosomatic Research. 2007;63(4):373–6.
19.
Mallinckrodt B, King JL, Coble HM. Family disfunction, alexithymia and client attachment to therapist. J Couns Psychol. 1998;56:737–45.
20.
Lumley MA, Mader C, Gramzow J, Papineau K. Family Factors Related to Alexithymia Characteristics. Psychosomatic Medicine. 1996;58(3):211–6.
21.
Fukunishi I, Paris W. Intergenerational Association of Alexithymic Characteristics for College Students and Their Mothers. Psychological Reports. 2001;89(1):77–84.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
